Cargando…

Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial

Objective To investigate the possibility that statins reduce blood pressure as well as cholesterol concentrations through clinic and 24 hour ambulatory blood pressure monitoring. Design Randomised placebo controlled double blind trial. Setting 13 hospitals in Italy Participants 508 patients with mil...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancia, Giuseppe, Parati, Gianfranco, Revera, Miriam, Bilo, Grzegorz, Giuliano, Andrea, Veglia, Fabrizio, Crepaldi, Gaetano, Zanchetti, Alberto
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845783/
https://www.ncbi.nlm.nih.gov/pubmed/20339154
http://dx.doi.org/10.1136/bmj.c1197
_version_ 1782179437151780864
author Mancia, Giuseppe
Parati, Gianfranco
Revera, Miriam
Bilo, Grzegorz
Giuliano, Andrea
Veglia, Fabrizio
Crepaldi, Gaetano
Zanchetti, Alberto
author_facet Mancia, Giuseppe
Parati, Gianfranco
Revera, Miriam
Bilo, Grzegorz
Giuliano, Andrea
Veglia, Fabrizio
Crepaldi, Gaetano
Zanchetti, Alberto
author_sort Mancia, Giuseppe
collection PubMed
description Objective To investigate the possibility that statins reduce blood pressure as well as cholesterol concentrations through clinic and 24 hour ambulatory blood pressure monitoring. Design Randomised placebo controlled double blind trial. Setting 13 hospitals in Italy Participants 508 patients with mild hypertension and hypercholesterolaemia, aged 45 to 70 years. Intervention Participants were randomised to antihypertensive treatment (hydrochlorothiazide 25 mg once daily or fosinopril 20 mg once daily) with or without the addition of a statin (pravastatin 40 mg once daily). Main outcome measures Clinic and ambulatory blood pressure measured every year throughout an average 2.6 year treatment period. Results Both the group receiving antihypertensive treatment without pravastatin (n=254) (with little change in total cholesterol) and the group receiving antihypertensive treatment with pravastatin (n=253) (with marked and sustained reduction in total cholesterol and low density lipoprotein cholesterol) had a clear cut sustained reduction in clinic measured systolic and diastolic blood pressure as well as in 24 hour, and day and night, systolic and diastolic blood pressure. Pravastatin performed slightly worse than placebo, and between group differences did not exceed 1.9 (95% confidence interval −0.6 to 4.3, P=0.13) mm Hg throughout the treatment period. This was also the case when participants who remained on monotherapy with hydrochlorothiazide or fosinopril throughout the study were considered separately. Conclusions Administration of a statin in hypertensive patients in whom blood pressure is effectively reduced by concomitant antihypertensive treatment does not have an additional blood pressure lowering effect. Trial registration BRISQUI_*IV_2004_001 (registered at Osservatorio Nazionale sulla Sperimentazione Clinica dei Medicinali—National Monitoring Centre on Clinical Research with Medicines).
format Text
id pubmed-2845783
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-28457832010-04-26 Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial Mancia, Giuseppe Parati, Gianfranco Revera, Miriam Bilo, Grzegorz Giuliano, Andrea Veglia, Fabrizio Crepaldi, Gaetano Zanchetti, Alberto BMJ Research Objective To investigate the possibility that statins reduce blood pressure as well as cholesterol concentrations through clinic and 24 hour ambulatory blood pressure monitoring. Design Randomised placebo controlled double blind trial. Setting 13 hospitals in Italy Participants 508 patients with mild hypertension and hypercholesterolaemia, aged 45 to 70 years. Intervention Participants were randomised to antihypertensive treatment (hydrochlorothiazide 25 mg once daily or fosinopril 20 mg once daily) with or without the addition of a statin (pravastatin 40 mg once daily). Main outcome measures Clinic and ambulatory blood pressure measured every year throughout an average 2.6 year treatment period. Results Both the group receiving antihypertensive treatment without pravastatin (n=254) (with little change in total cholesterol) and the group receiving antihypertensive treatment with pravastatin (n=253) (with marked and sustained reduction in total cholesterol and low density lipoprotein cholesterol) had a clear cut sustained reduction in clinic measured systolic and diastolic blood pressure as well as in 24 hour, and day and night, systolic and diastolic blood pressure. Pravastatin performed slightly worse than placebo, and between group differences did not exceed 1.9 (95% confidence interval −0.6 to 4.3, P=0.13) mm Hg throughout the treatment period. This was also the case when participants who remained on monotherapy with hydrochlorothiazide or fosinopril throughout the study were considered separately. Conclusions Administration of a statin in hypertensive patients in whom blood pressure is effectively reduced by concomitant antihypertensive treatment does not have an additional blood pressure lowering effect. Trial registration BRISQUI_*IV_2004_001 (registered at Osservatorio Nazionale sulla Sperimentazione Clinica dei Medicinali—National Monitoring Centre on Clinical Research with Medicines). BMJ Publishing Group Ltd. 2010-03-25 /pmc/articles/PMC2845783/ /pubmed/20339154 http://dx.doi.org/10.1136/bmj.c1197 Text en © Mancia et al 2010 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research
Mancia, Giuseppe
Parati, Gianfranco
Revera, Miriam
Bilo, Grzegorz
Giuliano, Andrea
Veglia, Fabrizio
Crepaldi, Gaetano
Zanchetti, Alberto
Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial
title Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial
title_full Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial
title_fullStr Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial
title_full_unstemmed Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial
title_short Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial
title_sort statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from phyllis randomised double blind trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845783/
https://www.ncbi.nlm.nih.gov/pubmed/20339154
http://dx.doi.org/10.1136/bmj.c1197
work_keys_str_mv AT manciagiuseppe statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial
AT paratigianfranco statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial
AT reveramiriam statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial
AT bilogrzegorz statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial
AT giulianoandrea statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial
AT vegliafabrizio statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial
AT crepaldigaetano statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial
AT zanchettialberto statinsantihypertensivetreatmentandbloodpressurecontrolinclinicandover24hoursevidencefromphyllisrandomiseddoubleblindtrial